Abstract:Due to public warnings from regulators and increased awareness among ordinary investors, fraudulent brokers are not as easy to get away with as they formerly were. A few scam artists may steal regulatory information from legitimate brokers and falsely claim to be licensed. However, many more scammers, such as VRN Capitals, work hard to avoid regulatory scrut

Fraudulent brokers are not as simple to get away with as they formerly were, due to public warnings from authorities and greater awareness among general investors. A small number of con artists may take regulatory information from reputable brokers and fraudulently pretend to be regulated. However, many more fraudsters, such as VRN Capitals, strive to evade regulatory inquiries.
There was no regulatory information discovered.
VRN Capitals advertises highly appealing trading conditions on its website, including low spreads, high leverage, and a minimum deposit of as little as $10. Client monies, according to the firm, are also secured by “Solid Regulatory Protection.” However, only the most significant regulatory information for investors, the regulatory number, and the regulator may be located in this dazzling pile of information.

We had no alternative except to track the broker's regulation through its contact details. The website indicates that the company's location is in the United Kingdom, and the phone number is likewise in the United Kingdom. So we looked for this company's license in the FCA. All we could uncover was a warning against the firm, which said that it supplied financial goods and services to UK people without authorization. This is obviously not legal.


More information on VRN Capitals may be found at https://www.wikifx.com/en/dealer/4277865872.html.

There are an increasing number of fraudsters on the market, such as VRN Capitals, who have the mentality of attempting to muddle through and never discussing anything about regulation. This is an apparent red signal for experts, and it is typically feasible to discover the right regulator for a licensing search via the nation where the firm is situated.
However, there is a great chance of falling for it for newcomers who are diverted from regulation by such a fraudster while also being drawn in by the appealing trading circumstances.
Stay tuned for more Forex Broker News.
Download the WikiFX App from the App Store or Google Play Store to stay updated on the latest news.


Have you had to encounter numerous denials on fund withdrawals by KapitalRS, a Serbia-based CFD broker? Were you asked to pay additional fees for withdrawal access? Did you incur losses on your forex positions due to the confusion concerning the bonus? Does your overall trading cost go up due to the wide spreads charged by the forex broker? These issues have arguably become the highlight on several broker review platforms. In this KapitalRS article, we have elaborated on numerous complaints against the brokerage firm. Take a look!

Trive, a Netherlands-based leading CFD broker across forex, stocks, indices and commodities, is facing ire from its employees on the unpaid salary crisis that has haunted them for four months starting from November 2025. Upset over such a long delay, employees have been using social media platforms to express their frustration. Read on for more revelation.

Did you have a good trading experience with LONG ASIA initially before it went bad, as you sought fund withdrawals from the platform? Did Saint Vincent and the Grenadines-based forex brokerage house deny you access to funds despite numerous withdrawal requests? Have you lost your funds because of this denial? Failing to log in despite numerous attempts? You are not alone! Many traders have accused the broker of these trading practices. In this LONG ASIA review article, we have highlighted some complaints against the broker. Read on as we share all these details with you.

The Financial Industry Regulatory Authority (FINRA) has filed a formal complaint against Spartan Capital Securities LLC, its CEO John Dennis Lowry, and its former Chief Compliance Officer (CCO) Kim Marie Monchik. The Department of Enforcement alleges a sophisticated scheme to defraud customers during a pharmaceutical company’s initial public offering (IPO), resulting in over $50 million in profits for the firm and its insiders while customers were left with dramatic losses.